VALIDITY OF THE AFFECTED DISCORDANT-SIB-PAIR DESIGN
VALIDITY OF THE AFFECTED DISCORDANT-SIB-PAIR DESIGN
批准号:
7600996
负责人:
CHENGGUO XING
金额:
$0.1万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-01 至 2008-07-31
关键词:
AdvocateAffectAlgorithmsAllelesComputer Retrieval of Information on Scientific Projects DatabaseEquilibriumFundingGene FrequencyGenotypeGrantInstitutionLinkLinkage DisequilibriumProbabilityRateRelative (related person)ResearchResearch PersonnelResourcesSingle Nucleotide PolymorphismSourceTestingUnited States National Institutes of Healthdesignstatistics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Genomewide linkage studies are tending toward the use of single-nucleotide polymorphisms (SNPs) as the markers of choice. However, linkage disequilibrium (LD) between tightly linked SNPs violates the fundamental assumption of linkage equilibrium (LE) between markers that underlies most multipoint calculation algorithms currently available, and this leads to inflated afected-relative-pair allele-sharing statistics when founders' multilocus genotypes are unknown. We investigated the impact that the degree of LD, marker allele frequency, and association type, have on estimating the probabilities of sharing alleles identical by descent in multipoint calculations and hence on type I error rates of different sib-pair linkage approaches that assume LE. We showed that marker-marker LD does not inflate type I error rates of affected sib pair ASP) statistics in the whole parameter space, and that, in any case, discordant sib pairs (DSP) can be used to control for marker-marker LD in ASPs. Thus, we advocate the ASP/DSP design with appropriate statistics that test the difference in allele sharing between ASPs and DSPs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Quantifying NNK metabolites to facilitate Kava lung cancer prevention clinical translation
-
批准号:10512091
-
项目类别:
-
资助金额:$7.63万
-
财政年份:2022
-
负责人:CHENGGUO XING
-
依托单位:
Quantifying NNK metabolites to facilitate Kava lung cancer prevention clinical translation
-
批准号:10683294
-
项目类别:
-
资助金额:$7.63万
-
财政年份:2022
-
负责人:CHENGGUO XING
-
依托单位:
Dihydromethysticin (DHM) for Lung Cancer Chemoprevention
-
批准号:9271168
-
项目类别:
-
资助金额:$31.66万
-
财政年份:2016
-
负责人:CHENGGUO XING
-
依托单位:
Dihydromethysticin (DHM) for Lung Cancer Chemoprevention
-
批准号:9070717
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2015
-
负责人:CHENGGUO XING
-
依托单位:
Mechanisms of Anticancer Agents Selective against Drug Resistant Leukemia
-
批准号:9093750
-
项目类别:
-
资助金额:$4.83万
-
财政年份:2012
-
负责人:CHENGGUO XING
-
依托单位:
Mechanisms of Anticancer Agents Selective against Drug Resistant Leukemia
-
批准号:8546311
-
项目类别:
-
资助金额:$28.79万
-
财政年份:2012
-
负责人:CHENGGUO XING
-
依托单位:
Mechanisms of Anticancer Agents Selective against Drug Resistant Leukemia
-
批准号:8369783
-
项目类别:
-
资助金额:$30.63万
-
财政年份:2012
-
负责人:CHENGGUO XING
-
依托单位:
Mechanisms of Anticancer Agents Selective against Drug Resistant Leukemia
-
批准号:8690558
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2012
-
负责人:CHENGGUO XING
-
依托单位:
An NF-kB inhibitor as a post-carcinogen lung cancer chemopreventive agent
-
批准号:8045025
-
项目类别:
-
资助金额:$7.32万
-
财政年份:2011
-
负责人:CHENGGUO XING
-
依托单位:
An NF-kB inhibitor as a post-carcinogen lung cancer chemopreventive agent
-
批准号:8223221
-
项目类别:
-
资助金额:$7.17万
-
财政年份:2011
-
负责人:CHENGGUO XING
-
依托单位:
Developing a Post-carcinogen Lung Cancer Chemopreventive Agent
-
批准号:8509621
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2010
-
负责人:CHENGGUO XING
-
依托单位:
Developing a Post-carcinogen Lung Cancer Chemopreventive Agent
-
批准号:7984110
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2010
-
负责人:CHENGGUO XING
-
依托单位:
Developing a Post-carcinogen Lung Cancer Chemopreventive Agent
-
批准号:8305153
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2010
-
负责人:CHENGGUO XING
-
依托单位:
Developing a Post-carcinogen Lung Cancer Chemopreventive Agent
-
批准号:8707983
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2010
-
负责人:CHENGGUO XING
-
依托单位:
Developing a Post-carcinogen Lung Cancer Chemopreventive Agent
-
批准号:8144291
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2010
-
负责人:CHENGGUO XING
-
依托单位:
Identification of Chemopreventive Agents Against Lung Tumorigenesis
-
批准号:7321423
-
项目类别:
-
资助金额:$7.48万
-
财政年份:2007
-
负责人:CHENGGUO XING
-
依托单位:
Identification of Chemopreventive Agents Against Lung Tumorigenesis
-
批准号:7472602
-
项目类别:
-
资助金额:$7.48万
-
财政年份:2007
-
负责人:CHENGGUO XING
-
依托单位:
Bcl-2 selective inhibitors: development and application to cancer treatment
-
批准号:7145178
-
项目类别:
-
资助金额:$20.82万
-
财政年份:2006
-
负责人:CHENGGUO XING
-
依托单位:
Bcl-2 selective inhibitors: development and application to cancer treatment
-
批准号:7478545
-
项目类别:
-
资助金额:$20.35万
-
财政年份:2006
-
负责人:CHENGGUO XING
-
依托单位:
Bcl-2 selective inhibitors: development and application to cancer treatment
-
批准号:7258840
-
项目类别:
-
资助金额:$20.35万
-
财政年份:2006
-
负责人:CHENGGUO XING
-
依托单位:
海外基金